Drugs / CD8 reduced peripheral blood cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04713046 | Oct 2023 → Oct 2026 expected | human papillomavirus-related squamous cell carcinoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD8 reduced peripheral blood cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04713046 ↗ |